Peroxisome proliferator-activated receptors in HBV-related infection.
Thirty years after its discovery, the hepatitis B virus (HBV) still remains a major global public health problem. Worldwide, two billion subjects have been infected, 350 million have a chronic infection and more than 600 000 die annually of HBV-related liver disease or hepatocellular carcinoma; new infections occur because of the presence of a large reservoir of chronic carriers of the virus. Since a decade several studies describe the interrelations between HBV and nuclear receptors and more particularly the peroxisome proliferator-activated receptors (PPARs). After a brief introduction, this review will make a rapid description of HBV incidence and biology. Then a report of the literature on the role of PPARs on viral transcription and replication will be developed. Finally, the role of HBV on PPARγ expression and activity will be discussed. Concluding remarks and perspectives will close this review.
Institute National de la Santé et de la recherche Médicale INSERM, U795, 59037 Lille, France.
Laurent
L
Dubuquoy
Alexandre
A
Louvet
Antoine
A
Hollebecque
Philippe
P
Mathurin
Sébastien
S
Dharancy